Definitive Healthcare Corp. DH R2K

Healthcare · Health Information Services · United States

https://www.definitivehc.com

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution. The company's platform consists of various functional areas, such as sales, marketing, clinical research and product development, strategy, talent acquisition, and physician network management. It serves biopharmaceutical and medical device companies, healthcare information technology companies, and healthcare providers; and other diversified companies comprising staffing and commercial real estate firms, financial institutions, marketing and advertising agencies.Definitive Healthcare Corp. was founded in 2011 and is headquartered in Framingham, Massachusetts.

Market & Price

Market Cap

$98.22M

Current Price

$0.93

High / Low (52W)

$4.30 / $0.81

Beta

1.34

Valuation

Stock P/E

Industry PE

23.65

Forward P/E

4.99

PEG Ratio

Book Value

$1.39

Price to Book

0.67

P/S

0.41

EV/EBITDA

3.62

Dividend Yield

Profitability & Returns

ROCE

-34.21%

ROE

-75.50%

ROA

-1.74%

Profit Margin

-71.49%

Op Margin

-8.65%

EPS (Latest Qtr)

$-1.32

EPS (TTM)

$-1.67

Balance Sheet & Liquidity

Debt/Equity

0.89

Quick Ratio

1.55

Current Ratio

1.75

Debt

$169.84M

Total Assets

$735.49M

Current Assets

$257.61M

Working Capital

$100.82M

Ownership

Promoter Holding

3.09%

Chg in Prom Hold

FII / Inst Holding

86.75%

Chg in FII Hold

Financial Snapshot

Enterprise Value

$134.28M

Total Revenue (TTM)

$238.26M

EBITDA

$37.11M

Free Cash Flow

$57.20M

Operating Cash Flow

$39.27M

Shares Outstanding

105.52M

Gross Margin

84.40%

Payout Ratio

0.00%

Growth (CAGR)

Revenue 5Y

2.75%

Profit 5Y

-607.91%

Revenue (YoY)

-5.50%

Earnings (YoY)

PROS

Generates positive free cash flow.

CONS

Earnings shrank at -607.9% CAGR over 5 years.
Trading 78.3% below its 52-week high.
In a downtrend (50-DMA below 200-DMA).

* The pros and cons are auto-generated from financial metrics.

Price Chart

Robinhood TradingView StockAnalysis

Fundamental Growth

Period: Metric:

Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).

Peer comparison

Peer companies in the same sector (Healthcare).

#	Name	CMP $	P/E	Mkt Cap	Div Yld %	ROCE %	ROE %	Rev CAGR 5Y %	Profit CAGR 5Y %
1	DH Definitive Healthcare Corp. R2K	0.93	-	$98.22M	-	-34.21%	-75.50%	2.75%	-607.91%
2	LLY Eli Lilly and Company SPX	1,105.00	39.21	$985.37B	0.63%	38.44%	107.46%	31.69%	48.96%
3	JNJ Johnson & Johnson SPX	225.33	26.11	$542.42B	2.38%	23.13%	26.42%	5.60%	14.32%
4	UNH UnitedHealth Group Incorporated SPX	380.31	28.66	$345.38B	2.32%	9.60%	12.18%	11.35%	-15.69%
5	MRK Merck & Co., Inc. SPX	118.72	33.44	$293.22B	2.86%	20.66%	18.94%	3.12%	7.93%
6	TMO Thermo Fisher Scientific Inc. SPX	492.51	27.11	$183.03B	0.38%	9.17%	13.52%	-0.27%	-1.19%
7	AMGN Amgen Inc. NDXSPX	336.79	23.42	$181.77B	2.99%	18.02%	101.32%	11.77%	5.58%
8	GILD Gilead Sciences, Inc. NDXSPX	134.43	18.29	$166.90B	2.44%	22.92%	43.36%	2.57%	22.83%
9	ISRG Intuitive Surgical, Inc. NDXSPXAI	424.64	51.53	$150.39B	-	15.96%	17.23%	17.39%	29.26%

Quarterly Results

Figures in USD.

Metric	Sep 2020	Mar 2021	Jun 2021	Sep 2021	Mar 2022	Jun 2022	Sep 2022	Mar 2023	Jun 2023	Sep 2023	Mar 2024	Jun 2024	Sep 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Revenue	30.07M	36.94M	39.82M	43.08M	50.12M	54.55M	57.38M	59.20M	60.96M	65.33M	63.48M	63.74M	62.70M	59.19M	60.75M	60.05M	61.53M	55.93M
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	15.43M	14.14M	14.05M	14.62M	14.28M
Gross Profit	22.66M	27.50M	29.95M	32.60M	38.80M	42.77M	47.66M	47.30M	49.79M	53.43M	50.38M	50.45M	49.03M	43.76M	46.61M	45.99M	46.91M	41.65M
Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	50.75M	50.11M	49.37M	53.62M	46.49M
Operating Income	-940.00K	-2.16M	-6.62M	-4.03M	-10.98M	-11.88M	-10.06M	-12.27M	-12.07M	-295.38M	-16.25M	-369.64M	-225.37M	-6.99M	-3.50M	-3.38M	-6.71M	-4.84M
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	-149.73M	8.52M	-209.00K	-439.00K	-179.91M
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-	2.43M	2.99M	3.00M	2.87M	2.63M
Pretax Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-165.98M	-8.81M	-17.27M	-17.20M	-195.79M
Tax Provision	-	-	-	-	-	-	-	-	-	-	-	-	-	-10.89M	456.00K	524.00K	-53.00K	-3.44M
Net Income	-	0	0	-7.98M	-8.62M	-5.49M	-3.02M	-12.06M	-8.57M	-171.53M	-9.52M	-213.63M	-130.90M	-107.23M	-7.55M	-14.84M	-9.31M	-138.62M
Diluted EPS	-	-	-	-0.09	-0.09	-0.06	-0.03	-0.11	-0.08	-1.50	-0.08	-1.81	-1.12	-0.95	-0.07	-0.14	-0.09	-1.32
R&D Expense	2.62M	3.79M	4.28M	4.75M	6.85M	8.71M	9.21M	9.88M	10.23M	10.76M	10.13M	10.12M	7.28M	9.30M	7.97M	7.55M	-	6.50M

Profit & Loss (Annual)

Figures in USD.

Metric	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Revenue	118.32M	-	222.65M	251.41M	252.20M	241.52M
Cost of Revenue	-	-	42.62M	47.48M	54.73M	58.25M
Gross Profit	87.85M	-	180.03M	203.93M	197.47M	183.28M
Operating Expenses	-	-	216.18M	234.84M	207.21M	203.86M
Operating Income	-14.45M	-	-36.15M	-30.91M	-9.74M	-20.58M
EBITDA	-	-	26.23M	-241.23M	-567.24M	-141.86M
Interest Expense	-	-	11.20M	15.20M	14.84M	11.29M
Pretax Income	-	-	-41.88M	-308.18M	-633.75M	-209.26M
Tax Provision	-	-	-17.70M	-18.55M	-42.30M	-9.96M
Net Income	0	-	-7.22M	-202.39M	-413.12M	-138.93M
Diluted EPS	-	-	-0.06	-1.79	-3.54	-1.30
R&D Expense	11.06M	18.57M	34.89M	42.44M	36.52M	34.78M

Compounded Sales Growth

5 Years:	2.75%
1 Year:	-5.50%

Compounded Profit Growth

5 Years:	-607.91%
1 Year:	-

Stock Price Performance

1 Year:	-71.87%
6 Months:	-66.75%
3 Months:	-27.27%
1 Month:	-0.43%

Balance Sheet (Annual)

Figures in USD.

Metric	Dec 2018	Jul 2019	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Assets	-	-	-	1.75B	-	2.12B	1.83B	1.09B	735.49M
Current Assets	-	-	-	-	-	413.75M	393.93M	370.17M	257.61M
Cash & Equivalents	19.36M	17.06M	8.62M	24.77M	-	146.93M	130.98M	105.38M	163.63M
Inventory	-	-	-	-	-	-	-	-	-
Receivables	-	-	-	-	-	59.78M	60.21M	54.62M	52.80M
Total Liabilities	-	-	-	549.80M	-	640.68M	626.73M	482.19M	356.50M
Current Liabilities	-	-	-	88.72M	-	140.61M	170.68M	161.16M	156.79M
Long Term Debt	-	-	-	457.20M	-	255.76M	242.57M	229.37M	156.09M
Total Debt	-	-	-	-	-	275.85M	267.93M	253.11M	172.67M
Total Equity	-	-	-	1.20B	-	948.92M	861.36M	444.38M	281.11M
Shares Outstanding	-	-	-	-	-	105.14M	116.56M	113.95M	104.02M

Cash Flows (Annual)

Figures in USD.

Metric	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Operating Cash Flow	23.22M	-	35.58M	41.19M	58.20M	53.78M
Investing Cash Flow	-23.86M	-	-248.90M	-31.78M	-26.41M	153.88M
Financing Cash Flow	16.66M	-	-26.70M	-25.58M	-56.75M	-150.79M
Capital Expenditure	-1.40M	-	-8.33M	-2.98M	-12.34M	-16.72M
Free Cash Flow	21.82M	-	27.25M	38.21M	45.85M	37.06M
Net Change in Cash	-	-	-240.02M	-16.18M	-24.96M	56.86M
Share Buybacks	-	-	0	0	22.37M	49.45M

Ratios (Annual)

Figures in %.

Metric	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Gross Margin %	74.2%	-	80.9%	81.1%	78.3%	75.9%
Operating Margin %	-12.2%	-	-16.2%	-12.3%	-3.9%	-8.5%
Net Margin %	0.0%	-	-3.2%	-80.5%	-163.8%	-57.5%
ROE %	0.0%	-	-0.8%	-23.5%	-93.0%	-49.4%
ROCE %	-0.9%	-	-1.8%	-1.9%	-1.0%	-3.6%

Shareholding Pattern

Insiders

3.09%

Institutions

86.75%

Public Float

89.52%

Top Institutional Holders

#	Holder	% Held	Shares	Value
1	Advent International LP	59.22%	62.49M	$58.17M
2	Goldman Sachs Group Inc	5.73%	6.04M	$5.63M
3	Blackrock Inc.	2.83%	2.99M	$2.78M
4	Shaw D.E. & Co., Inc.	1.99%	2.10M	$1.95M
5	Vanguard Capital Management LLC	1.77%	1.87M	$1.74M
6	Dimensional Fund Advisors LP	1.58%	1.67M	$1.55M
7	Geode Capital Management, LLC	1.12%	1.18M	$1.10M
8	State Street Corporation	0.81%	856.18K	$796.93K
9	AQR Capital Management, LLC	0.67%	702.02K	$653.44K
10	Millennium Management Llc	0.56%	590.38K	$549.53K

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for DH

No recent headlines available.

DH · Healthcare